---
$id: https://graph.org.ai/products/commodity/51161557
$type: Product
source: UNSPSC
code: "51161557"
title: "Zardaverine"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Zardaverine

**UNSPSC Code**: 51161557
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor and bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TQ358GWH6Y. European Medicines Agency schedules Zardaverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00142MIG. Zardaverine generally arises in the molecular formula C12H10F2N2O3. The term ZARDAVERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, no. 3, 1989, list 29.) ZARDAVERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zardaverine under HS 29339990 and SITC 51577. As of Q4 2014, ZARDAVERINE remains the US FDA Preferred Term for this commodity. Zardaverine bears US NLM identifiers UMLS ID C0085049 and NCI Concept Code C66686. SMILES: COC1=C(C=CC(=C1)C2=NNC(=O)C=C2)OC(F)F.

